News

FDA Approves a Twice-Yearly Shot to Prevent HIV
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Highlights NV-387 As Broad-Spectrum Antiviral Candidate For COVID And Bird Flu Preparedness
NanoViricides, Inc. (NYSE American: NNVC) asserts that its antiviral candidate NV-387 is uniquely positioned to address rising global threats from em ...